title: Surgical biology for the clinician: vascular effects of immunosuppression.
authors.affiliation: Division of Cardiovascular Surgery, University Health Network, Toronto, Ont.
authors.forename: Elissa
authors.initials: E
authors.lastname: Tepperman
authors.forename: Danny
authors.initials: D
authors.lastname: Ramzy
authors.forename: Jessica
authors.initials: J
authors.lastname: Prodger
authors.forename: Rohit
authors.initials: R
authors.lastname: Sheshgiri
authors.forename: Mitesh
authors.initials: M
authors.lastname: Badiwala
authors.forename: Heather
authors.initials: H
authors.lastname: Ross
authors.forename: Vivek
authors.initials: V
authors.lastname: Raoa
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D001379:Azathioprine / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology*; D051799:Delayed Graft Function / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology* / Q000503:physiopathology; D000068338:Everolimus; D006084:Graft Rejection; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D007108:Immune Tolerance / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000494:pharmacology*; D016559:Tacrolimus / Q000494:pharmacology*; D014181:Transplantation Immunology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D001379:Azathioprine; D020123:Sirolimus; D016559:Tacrolimus